Developed by Soviet physiologist Konstantin Buteyko in 1950s. First official study conducted in 1968 at Leningrad Institute. Method introduced to Australia, New Zealand, Britain and US
Nebulizer delivers medication as mist inhaled into lungs. Uses oxygen, compressed air or ultrasonic power to break solutions. Commonly used for asthma, cystic fibrosis and COPD treatment
Preferred InChI key: LHLMOSXCXGLMMN-WDTICOSOSA-M. Used as respiratory aerosol at 20 µg per dose. Classified as antiasthmatic and medicine for COPD
Molecular formula: C35H35ClNNaO3S. Chemical name: sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate. Common synonyms include Singulair, Montelukast sodium, and Montelukast monosodium salt
Montelukast treats asthma in patients 12 months and older. Prevents exercise-induced bronchoconstriction in patients 6 years and older. Relieves seasonal allergic rhinitis symptoms in patients 2 years and older
Contains budesonide 160mcg and formoterol fumarate 4.5mcg per inhaler. Available in 60- and 120-count inhaler strengths. Supplied as pressurized aluminum canister with counting device